Saba Capital Management’s SomaLogic, Inc. Warrant SLGCW Stock Holding History

Saba Capital Management’s Portfolio SLGCW Stock Details SLGCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-98,882	Closed	-$14.4K	–	517
2023 Q4	$14.4K	Hold	98,882	–	–	﹤0.01%	398
2023 Q3	$21.8K	Hold	98,882	–	–	﹤0.01%	449
2023 Q2	$26.7K	Hold	98,882	–	–	﹤0.01%	471
2023 Q1	$27.1K	Hold	98,882	–	–	﹤0.01%	601
2022 Q4	$39.6K	Buy	98,882 +1,905	+2%	+$758	﹤0.01%	677
2022 Q3	$43K	Buy	+96,977	New	+$64.6K	﹤0.01%	864

Other funds holding SLGCW

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Saba Capital Management's SLGCW Position: Q1 2024 in Review

Saba Capital Management sold out of SomaLogic, Inc. Warrant (SLGCW) in Q1 2024, closing a stake of 98,882 shares — an estimated $14.4K sold.

Saba Capital Management first reported a position in SLGCW in Q3 2022 and held it in 6 quarters. The position peaked at $43K in Q3 2022. 4 funds tracked by Wall St. Rank hold SLGCW as of Q1 2024.

Saba Capital Management reported no remaining SomaLogic, Inc. Warrant position as of Q1 2024 after selling out during the quarter.
Saba Capital Management sold 98,882 SomaLogic, Inc. Warrant shares in Q1 2024, an estimated $14.4K.
Saba Capital Management first reported a position in SomaLogic, Inc. Warrant in Q3 2022 and held it in 6 quarters.
Saba Capital Management's SomaLogic, Inc. Warrant position peaked at $43K in Q3 2022.
4 funds tracked by Wall St. Rank held SomaLogic, Inc. Warrant as of Q1 2024.

Based on Saba Capital Management's 13F filing for Q1 2024, filed 15 May 2024.